A Study to Measure the Stigma of Skin Disorders as Experienced by Children
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 18-004673
Sponsor Protocol Number: ASP02172016
About this study
This study leverages the availability of a validated series of instruments to measure the effect of highly visible, chronic skin disorders, including atopic dermatitis (AD), on patients 8 years of age and above in causing stigma and psychiatric issues, particularly anxiety and depression.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Subjects must be aged 8-17 years of age
- Subject must be diagnosed with a chronic skin disease deemed to be severe enough and/or in a visible location that could be stigmatizing as determined by the study doctor
- Subject and parent must both be English speaking with at least one parent/guardian who will complete the questionnaires
- Subject and Parent/Guardian must be able to complete the relevant questionnaires
Exclusion Criteria:
- Children under 8 years of age
- Children with developmental delay and/or a behavioral disorder that would preclude participation in form completion
- Children with a non-cutaneous disorder that is considered by the Study doctor to be stigmatizing
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Megha Tollefson, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available